超声引导聚多卡醇硬化治疗甲状腺出血型囊性结节的初步研究  

Preliminary study of ultrasound-guided percutaneous polidocanol injection in hemorrhagic cystic thyroid nodules

作　　者：高侃[1] 王飞亮 彭艳 艾欣 陈秀华[1] 贾晓凡[3] 缪刚[4] 戴维德[1] Gao Kan;Wang Feiliang;Peng Yan;Ai Xin;Chen Xiuhua;Jia Xiaofan;Miao Gang;Dai Weide(Department of Ultrasound Medicine,Beijing Hospital,National Center of Gerontology,Beijing 100730,China)

机构地区：[1]国家老年医学中心北京医院超声医学科,北京100730 [2]青海省果洛州玛沁县人民医院超声科 [3]国家老年医学中心北京医院内分泌科,北京100730 [4]国家老年医学中心北京医院甲状腺外科,北京100730

出　　处：《中国临床保健杂志》2018年第6期785-788,共4页Chinese Journal of Clinical Healthcare

基　　金：国家科技支撑计划课题(2014BAI08B03)

摘　　要：目的评估超声引导新型硬化剂聚多卡醇治疗出血型甲状腺囊性结节的疗效及安全性。方法回顾性分析住院治疗的15例超声引导聚多卡醇硬化治疗的出血型甲状腺囊性结节的临床资料。所有结节均于术后1周、1个月和3个月进行随访。评估结节体积、不良反应率、总有效率及复发率。结果聚多卡醇硬化治疗总有效率为93.3%,不良反应发生率为13.3%,复发率为6. 7%。结论超声引导聚多卡醇硬化治疗出血型甲状腺囊性结节方法简便实用,安全有效。Objective To evaluate the efficacy and safety of ultrasound-guided percutaneous polidocanol injection in treating of hemorrhagic cystic thyroid nodules. Methods A total of 15 patients who were admitted by our hospital with hemorrhagic cystic thyroid nodules treated by ultrasound-guided percutaneous polidocanol injection from Nov 2017 to Feb 2018 were enrolled retrospectively in this study.The nodules were followed up after 1 week,1 months and 3 months after the surgery.Nodule volumes,complication rates,therapeutic success rates and recurrence rates were assessed. Results The therapeutic success rate for ultrasound-guided sclerotherapy with polidocanol was 93.3%.The complication rate was 13.3% and recurrence rate was 6.7%. Conclusion Ultrasound-guided percutaneous polidocanol injection is effective and safe as an simple and practical alternative method in curing hemorrhagic cystic thyroid nodules.

关 键 词：甲状腺结节 硬化疗法 超声检查 介入性 

分 类 号：R581.5[医药卫生—内分泌]